Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
批准号:
10516346
负责人:
STEVEN C. SCHACHTER
金额:
$20.34万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-06-30
关键词:
AddressAdvocateAreaCaregiversCollaborationsCommunicationCommunitiesCustomDevelopmentDiagnosisElectronic MailEvaluationFaceFocus GroupsFundingIncubatorsIndustryInterdisciplinary StudyLeadershipLogisticsMentorsMethodsNeeds AssessmentOutcomePatientsPerformancePress ReleasesProcessProfessional OrganizationsPublicationsResearchRiskServicesTechnologyTrainingTranslational ResearchUnited States National Institutes of HealthVoicebasecommercializationdiversity and equityeducation researchexperienceinnovationinterestmeetingsnervous system disordernewsoutreachprogramsresearch data disseminationsocial mediasuccesstoolweb site
中文摘要
摘要-外展核心
外联核心将是CINTA的公共形象和沟通中心。的指导下
在行政协调小组和指导委员会的后勤支助下,
核心,外联核心负责利用
各种方法,包括需求评估、征集公告、新闻和教育、研究
传播,并与其他受资助的中心协作。捕捉和放大病人的声音,
照顾者和多样化、代表性不足的社区将是一项核心指导原则。CIMIT数十年来
在转化研究和多学科合作方面的经验。自1998年成立以来,CIMIT
支持了近800个创新项目,包括年度需求评估,招标,
为创新者提供个性化支持,并有针对性地传播相关信息。拟议的CINTA
外展核心将借鉴支持这些NIH项目的经验和教训,
将进一步创新工艺。CINTA将进行年度需求评估和利益攸关方外联
支持NIH参与组织的兴趣领域。开展年度需求的战略
评估将根据指导委员会和消费者咨询委员会的意见进行。这些
已经组成了小组,以广泛反映NIH参与组织的重点领域。
CINTA将采用CIMIT在过去几年中采用的方法,并通过以下方式广泛吸引利益相关者的参与:
使用社交媒体和Zoom焦点小组来确定神经系统疾病的未满足需求。
这些会议将包括病人倡导者、非营利组织和慈善组织的观点,
专业团体、学术研究团体、行业、付款人和其他人。批准名单年度科研
需求评估将提交给美国国家航空和宇宙航行局领导层,以制定适当的性能标准
基于技术的解决方案将对解决已确定的未满足问题产生最大影响的规范
需求规格将包含在招标文件中,并将作为评估的审查标准
核心外联核心将加强导师团队、顾问和主题专家的努力,
培训受资助的团队,包括举办“投资者论坛”,将子项目团队与潜在的
投资者CINTA将与其他中心合作,规划年度会议和出版物以供分享
成果和经验教训。CINTA将促进受资助中心之间的通信,
传播成果和经验教训。如果愿意,CINTA将很乐意建造和维护一个
蓝图医疗技术:孵化器中心计划的具体网站将在其他中心共享。创建
Blueprint MedTech:孵化器中心计划和获奖者的公开陈述至关重要,
成功项目启动的新闻稿可以通过电子邮件、社交媒体、
以及可选地通过新闻通讯社或新闻列表。
英文摘要
Abstract - OUTREACH CORE
The Outreach Core will be the public face and communications center for CINTA. Under the direction of the
CINTA Coordination Team and the Steering Committee, and with logistical support from the Administrative
Core, the Outreach Core is responsible for broad outreach to a diverse community of stakeholders using a
variety of methods including needs assessments, solicitation announcements, news and education, research
dissemination, and collaboration with the other funded hubs. Capturing and amplifying the voices of patients,
caregivers, and diverse, underrepresented communities will be a central guiding principle. CIMIT has decades
of experience in translational research and multidisciplinary collaboration. Since its founding in 1998, CIMIT
has supported nearly 800 innovative projects, including annual needs assessments, issuance of solicitations,
customized innovator support, and targeted dissemination of relevant information. The proposed CINTA
Outreach Core will build upon the experience and lessons learned from supporting these NIH programs and
will add further process innovations. CINTA will conduct annual needs assessments and stakeholder outreach
to support the areas of interests of the NIH Participating Organizations. Strategies for conducting annual needs
assessments will be based on input from the Steering Committee and Consumer Advisory Board. These
panels have been constituted to broadly reflect the areas of emphasis of the NIH Participating Organizations.
CINTA will use methods that CIMIT has employed in past years and will also broadly engage stakeholders by
use of social media and Zoom focus groups for identifying unmet needs for disorders of the nervous system.
These sessions will include the perspectives of patient advocates, nonprofit and philanthropic organizations,
professional societies, the academic research community, industry, payers, and others. Results of annual
needs assessments will be presented to CINTA leadership to develop appropriate criteria for performance
specifications where technology-based solutions would have the highest impact to address identified unmet
needs. Specifications will be included in the solicitation and will be used as review criteria by the Evaluation
Core. The Outreach Core will augment efforts by Mentor Teams, consultants, and subject matter experts to
train funded teams, including conducting an “Investor Forum” to connect subproject teams with potential
investors. CINTA will collaborate with other hubs to plan annual meetings and publications for sharing
outcomes and lessons learned. CINTA will facilitate communications among funded hubs and internal
dissemination of outcomes and lessons learned. If desired, CINTA will be pleased to construct and maintain a
Blueprint MedTech: Incubator Hubs program-specific website to be shared among the other hubs. Creating a
public narrative for both the Blueprint MedTech: Incubator Hubs program and for awardees is critical to
success. Press releases for program launch can be developed and disseminated through email, social media,
and, optionally, via a press wire service or press list.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for Innovative NeuroTech Advancement (CINTA) - Evaluation Core
-
批准号:10707297
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
-
批准号:10516345
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
-
批准号:10707293
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
-
批准号:10707291
-
项目类别:
-
资助金额:$245.33万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Evaluation Core
-
批准号:10516347
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
FEASIBILITY OF A COMBINED SEIZURE DETECTOR-VNS SYSTEM
-
批准号:7718938
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2008
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EVALUATION OF ADD ON 534U87 TREATMENT OF PARTIAL SEIZURES
-
批准号:6118949
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
-
批准号:6265420
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF GP47779 (NHD OF OXCARBAZEPINE) ADMINISTERED IV TO INPATIENTS
-
批准号:6265423
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EXTENSION TRIAL OF OXCARBAZEPINE IN PATIENTS W/ PARTIAL SEIZURES
-
批准号:6265424
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
PREGABALIN OPEN LABEL, FOLLOW ON SAFETY TRIAL IN PATIENTS W/ EPILEPSY
-
批准号:6265422
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
PREGABALIN IN PATIENT MONOTHERAPY TRIAL IN PATIENTS W/ EPILEPSY
-
批准号:6265421
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
VAGUS NERVE STIMULATION FOR ADJUNCTIVE TREATMENT OF EPILEPSY
-
批准号:6250105
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE AS MONOTHERAPY FOR COMPLEX PARTIAL SEIZURES
-
批准号:2637100
-
项目类别:
-
资助金额:$3.2万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF OXCARBAZEPINE IN PATIENTS WITH PARTIAL SEIZURES
-
批准号:6279904
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EVALUATION OF ADD ON 534U87 TREATMENT OF PARTIAL SEIZURES
-
批准号:6279969
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF OXCARBAZEPINE IN PATIENTS WITH PARTIAL SEIZURES
-
批准号:6250075
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE IN TREATMENT OF COMPLEX CHILDRENS HOSPITAL
-
批准号:2741400
-
项目类别:
-
资助金额:$13.85万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE IN TREATMENT OF COMPLEX CHILDRENS HOSPITAL
-
批准号:6193325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
REMACEMIDE INPATIENT SEIZURE EVALUATION TRIAL
-
批准号:6250146
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
海外基金